Current Medicine · 2024 · 22 citations · 100 references
MedicineImmunologyOncologyCancer ImmunologyTumor ImmunologyTumor MicroenvironmentCancer ImmunotherapyGlioblastomaImmunotherapy For Brain TumorsMacrophage BiologyTumor Immune MicroenvironmentTumor-associated MacrophagesCancer-associated MacrophagesGlioblastoma ImmunologyGlioblastoma ImmunotherapyGlioblastoma Tumor MicroenvironmentImmune System ModulationImmunological MechanismsPolarizationTumor Microenvironment Effects
Abstract Glioblastoma (GBM) is a malignant brain glioma characterized by a high number of tumor-associated macrophages (TAMs) within its tissues. These TAMs have a close relationship with tumor grade and prognosis. Targeting TAMs has been identified as a promising therapeutic strategy. However, TAM cells play both tumor-killing and tumor-promoting roles, making them a double-edged sword in the immune environment. The different subtypes of macrophages and their effects on the tumor microenvironment remain poorly understood. This study comprehensively elucidates the immunobiology of glioma-associated macrophages (GAMs), including their origin, classification, molecular mechanisms underlying glioma promotion and inhibition, polarization strategies, targeted therapy for GAMs and the current challenges and perspectives in immune modulation. Further research on macrophage function and mechanism may provide a new immunological basis for treating GBM patients and enhancing the efficacy of glioma immunotherapy.
100
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel, Julie Laffy, Mariella G. Filbin et al. · Cell · 2019 · 2.9K citations · Full text
Medicine, Cancer Biology, Genetics +14
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert, James J. Dignam, Terri S. Armstrong et al. · New England Journal of Medicine · 2014 · 2.8K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck, Leila Akkari, Alberto J. Schuhmacher et al. · Nature Medicine · 2013 · 2.5K citations · Full text
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira Barkal, Rachel Brewer, Maxim Markovic et al. · Nature · 2019 · 1.4K citations
Life Sciences, Immunology, Oncology +14